stars 1 stars 2 stars 3

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. We have a diversified and growth-oriented commercial product portfolio. Key therapeutic areas are Inflammation and Genetics & Metabolism. Our late stage pipeline includes three phase III programs with substantial potential. We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners. Our sales and marketing organization covers about 20 countries in Europe and a subsidiary in the US. We are also represented through partners in in the Middle East, Australia and New Zealand. In 2012, Sobi had total revenues of SEK 1.9 billion (€ 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com.

View Top Employees from Swedish Orphan Biovitrum AB (Sobi)
Website http://www.sobi.com
Ticker SOBI
Revenue $1.61 billion
Funding $152.5 million
Employees 161 (104 on RocketReach)
Founded 2001
Phone (468) 697-2000
Fax (468) 697-2330
Technologies
Industry Biotechnology, Pharmaceuticals, Drug Manufacturing & Research, Dedicated to rare diseases, Science and Engineering, Drug Discovery, Key therapeutic areas are Inflammation and Genetic diseases, wit, Healthcare, Genetics, A pioneer in biotechnology with world-class capabilities in prot, Medical Testing & Clinical Laboratories, Health Care
Web Rank 2 Million
Keywords Biotechnology, Rare Disease, Biologics, Pharmaceutical Manufacturing, Therapeutic Activities, Autoimmune Disease, Pharmaceutical Services
Competitors 3SBio Inc., Amneal Pharmaceuticals, Dr Reddy's NZ Ltd, Endo International plc, Recordati
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies

Swedish Orphan Biovitrum AB (Sobi) Questions

The Swedish Orphan Biovitrum AB (Sobi) annual revenue was $1.61 billion in 2024.

Carin Dahlquist is the Senior Director, Legal Affairs of Swedish Orphan Biovitrum AB (Sobi).

104 people are employed at Swedish Orphan Biovitrum AB (Sobi).

Swedish Orphan Biovitrum AB (Sobi) is based in Ase, Vasternorrlands Lan.

The NAICS codes for Swedish Orphan Biovitrum AB (Sobi) are [3254, 32, 32541, 325].

The SIC codes for Swedish Orphan Biovitrum AB (Sobi) are [28, 283].

Top Swedish Orphan Biovitrum AB (Sobi) Employees

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users